Effects of endotoxin on endothelin receptor in hepatic and intestinal tissues after endotoxemia in rats

Abstract

Key Words: endotoxin; endothelin receptor; liver; intestines; rats

INTRODUCTION

Endothelins (ETs) has a potent and sustained vasoconstrictive effect on a variety of blood vessels. The vascular smooth muscle cell (VSMC) is the target for ETs. VSMC of the whole body contains endothelin receptor (ETR)[1]. A great number of experiments have shown that three distinct complementary DNAs of ETR have been identified i.e., endothelin A receptor (ET-A receptor), endothelin B receptor (ET-B receptor) and endothelin C receptor (ET-C receptor). ET-A receptor was expressed in VSMC responsible for the contraction[2]. The aim of this study is to confirm the effects of endotoxin on the activity of ETR, and the transcription and expression of ET-A receptor mRNA in hepatic and intestinal tissues.

MATERIALS AND METHODS

Materials

Endotoxin (O111:B4) and porcine endothelin-1 (ET-1) were purchased from Sigma Chemical Co. ¹²⁵I-ET-1 was supplied by Isotope Institute of Chinese Academy of Sciences. Digoxigenin DNA labeling and Detection Kit was provided by Boehringer Mannheim Co.

Methods

Thirty male and female Wistar rats weighing 210 g-215 g were fasted with access to water ad libitum for 24 h before experiment. Six rats were used as the control group. The others were given endotoxin at a dose of 10 mg/kg as an end otoxin-treated group. All rats were killed at the 3rd, 6th, 12th, and 24th hour after administration of endotoxin and saline, with 6 rats in each group at each time point. After sacrifice by decapitation at the respective time points, the right hepatic and intestinal tissues were immediately removed and preserved in liquid nitrogen for use.

The hepatic and intestinal plasma membrane was prepared by the method of Koseki and Imari[3] with minor modifications. The hepatic and intestinal tissue was homogenized in 10 vol (wt/vol) of 0.25 mol sucrose including 1 mmol EDTA, and the homogenate was centrifuged at 10000 × g for 10 min. The supernatant was centrifuged at 100000 × g for 1 h. The entire procedure was performed at 4 °C. The resulting pellet was resuspented in 200 μL of 0.25 mol/L sucrose including 1 mmol EDTA, and kept in the deep freezer for assay. Twenty μL aliquot of the microsomal fraction, containing 20 μg-protein in 0.25 mol sucrose including 1 mmol EDTA, was ke pt at 4 °C for 24 h, with various concentrations of ¹²⁵I-ET-1 in 20 μL of the incubation solution. Twenty μL of ice-cold incubation solution was added and then centrifuged at 80000 × g at 4 °C for 30 min. The supernatant was rapidly aspirated. The radioactivity was determined with an FJ-2108 liquid scintillation counter. Specific binding was determined by the total binding minus the nonspecific binding. The maximal binding capacity (Bmax) and affinity (Kd) of ETR were obtained using Scatchard plot analysis.

Total cellular RNA was isolated from the hepatic and intestinal tissue with guanidinium thiocyanate-phenol-chloroform method[4]. Dot blot was used to identify and quantify ET-A receptor mRNA. Results were scanned in the computer to determine their quantity.

Statistical analysis

The data were expressed as mean ± SD. The difference between the groups was analyzed with Student′s t test. The difference was considered significant at P ＜ 0.05.

RESULTS

The change of activity of hepatic and intestinal ETR

The values of the Bmax and Kd of ETR of the normal hepatic and intestinal tissue are shown in Figure 1, Figure 2. The Kd of ETR was 0.0328 in normal hepatic tissue, and 0.1263 in normal intestinal tissue. The Bmax of ETR was 1.0288 in normal hepatic tissue, and 1.2303 in normal intestinal tissue. The Bmax of ETR of the hepatic and intestinal tissue decreased gradually during endotoxemia. The Bmax of ETR in the endotoxin-treated group decreased more significantly than that in the control group at the 3rd hour after endotoxin administration (P ＜ 0.01). The decrease of Bmax lasted 24 h. But the Kd of the hepatic and intestinal tissue did not change (Table 1).

Table 1 Effects of endotoxin on ETR of hepatic and intestinal tissue.

	Control	Endotoxin-treated group
		3rd	6th	12th	24th (h)
Liver
Bmax (bB/pmol•mg¯¹p)	0.9969 ± 0.0155	0.7476 ± 0.0356b	0.5590 ± 0.0219b	0.4258 ± 0.0156b	0.5826 ± 0.0586b
Kd (CB/nmol•L¯¹)	0.0328 ± 0.0018	0.0338 ± 0.0016	0.0332 ± 0.0014	0.0324 ± 0.0010	0.0333 ± 0.0017
Intestine
Bmax (bB/pmol•mg¯¹p)	1.2950 ± 0.2070		0.8810 ± 0.1026a	0.6340 ± 0.2109b	0.5199 ± 0.2260b
Kd (CB/nmol•L¯¹)	0.1309 ± 0.0183	0.1344 ± 0.0140	0.1181 ± 0.0173	0.1281 ± 0.0173	0.1260 ± 0.0169

^aP ＜ 0.05,

^bP ＜ 0.01 vs control group.

Figure 1 Specific binding of ¹²⁵I-ET-1 on liver hemogenates and corresponding Scatchard plot for normal rats. KDa = 0.0328 nM, Bmax = 1.0288 pmol/mg

Figure 2 Specific binding of ¹²⁵IET-1 on intestine hemogenates and corresponding Scatchard plot for normal rats. KDa = 0.1263 nM, Bmax = 1.2303 pmol/mg

The change of the relative quantity of ET_A receptor mRNA of hepatic and intestinal tissue

The relative quantity of ET_A receptor mRNA of hepatic tissue in the endotoxin -treated group increased more significantly than that in the control group at 3-24 h (P ＜ 0.01). It increased most obviously at the 6th and the 12th hour after endotoxin administration (Table 2). Compared with the control group, the relative quantity of ET-A receptor mRNA of intesti nal tissue in endotoxin-treated group also increased significantly between the 3rd and 12th hour after endotoxin administration (P ＜ 0.01) (Table 2).

Table 2 Effect of endotoxin on relative quantity of hepatic and inte stinal ET-A receptor nRNA (μg DNA/g RNA).

	Control	Endotoxin-treated group
		3rd	6th	12th	24th (h)
Liver	17.13 ± 2.11	57.96 ± 11.51b	86.35 ± 16.01b	95.50 ± 13.24b	27.93 ± 3.05b
Intestine	38.43 ± 3.86	48.32 ± 4.31b	69.42 ± 8.21b	68.61 ± 10.24b	42.41 ± 3.73

^bP ＜ 0.01 vs control group.

DISCUSSION

ETs have been shown to be one of the most potent vasoconstrictors, which are produced not only by vascular endothelial cells, but also by a variety of non-endothelial cells, and have many biological functions[5]. ETs should be combined with ETR of target cell, and activate a variety of signal transduction pathways so as to produce specific cellular responses[6]. This study showed that the Kd of ETR of hepatic and intestinal tissue did not change during endotoxemia. The Bmax of ETR of hepatic and intestinal tissue in endotoxin-treated group decreased more significantly in early stage than that in control group. Decrease of the Bmax of ETR lasted 24 h. The Bmax of ETR number of hepatic and intestinal tissue was the lowest at the 12th hour. After giving endotoxin, decrease of the ETR number of the hepatic and intestinal cell membrane was correlated with increase of ET-1 concentration (unpublished observation). Roubert et al[7] reported that the 50%receptors of VSMC in culture were induced by 10^-9 mol ET-1. During endotoxemia, the higher level of ET-1 was, the more ET-1 combined with the receptor, the lower number of receptor of cell membrane was, because the receptors of cell membrane combining with ET-1 squeezed into cells.

The relative quantity of ET_A receptor mRNA of hepatic and intestinal tissue increased obviously after endotoxin administration. This study showed that endotoxin could regulate transcription and translation of ET_A receptor mRNA. The results of ETR binding assay and ET_A receptor Dot blot analysis showed that the ETR number of hepatic and intestinal cell membrane decreased, but the relative quantity of ET_A receptor mRNA of hepatic and intestinal tissue increased obviously in endotoxemia. It was likely that a mechanism of auto-regulation existed in the body. Down-regulation of ETR may be helpful in preventing endothelin from hyperconstraction and reducing damage of tissues and organs. So it suggested that ETR may play an important role in the hepatic and intestinal pathophysiologic process following endotoxemia.